Genetics

One Cancer Mutation Especially Vulnerable

Published in Gene Therapy Weekly, August 10th, 1998

Tumors caused by one of the genetic mutations known to cause cancer seem especially vulnerable to standard cancer treatments, researchers said.

They said cancers linked to the BRCA2 gene were many times more sensitive to certain cancer drugs and to radiation than other types of cancer.

Writing in the Journal of the National Cancer Institute, the researchers said this could mean that some types of genetic screening could tell doctors not only who might be at the worst risk of cancer, but which treatment might work best.

"This is an exciting strategy because it takes what we know about a genetic defect that causes cancer and uses...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1998-08-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry